The application portal for UPSC NDA (I) registration is going to close tomorrow. Interested candidates can apply for the 394 ...
The Union Public Service Commission (UPSC) will soon close the online application process for the NDA and CDS 2026.
Aquestive's issues are more likely related to manufacturing or packaging rather than efficacy or safety. See why I'm ...
UPSC NDA & CDS 1 2026 Registration ends today (Dec 30) at 6 PM. Apply now at upsconline.nic.in. Check eligibility, fees, and ...
Two NDA submissions expected by mid-February 2026 for ulixacaltamide in essential tremor and relutrigine in SCN2A/8A-DEEs, ...
Bitopertin was awarded the Commissioner’s National Priority Review Voucher (CNPV) and NDA is currently under FDA reviewUpdated data from the ...
Dose selection from Phase 2/3 Duravelo-2 trial and update on potential approval pathway expected in 1Q 2026 as company seeks feedback from multiple regulatory agenciesEmerging radiopharmaceuticals ...
New Drug Application (NDA) for NonAdvSM submitted in December 2025, NDA submission for AdvSM on track for 1H 2026NDA submission for GIST on track for April 2026; bezuclastinib has the potential to be ...
Preliminary unaudited Q4 and Full Year 2025 net Attruby® product revenue of $146.0 million and $362.4 million, respectively- Attruby ...
The FDA has granted an in-person Type C meeting during the first quarter of 2026 New independent analyses across large observational ALS cohorts demonstrate that modest (~10%) NfL reductions are ...